NEOGENOMICS INC — Director's Dealing 2017

Mar 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-02-27

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-27	Common Stock	M	6250	$1.69	Acquired	13383	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-27	Stock Option (Right to Buy)	$1.69	X	6250	Disposed	2017-04-12	Common Stock (6250)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.76	2018-04-16	Common Stock (7500)	7500	Direct
Stock Option (Right to Buy)	$3.45	2019-03-05	Common Stock (15000)	15000	Direct
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (120000)	120000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (50000)	50000	Direct

Footnotes

F1: On April 12, 2012, Jennifer Balliet was granted 12,500 stock options. One quarter of these options vested immediately and the remaining options vested on the next three anniversary dates of the grant date. Jennifer Balliet previously exercised 6,250 of these options and is currently exercising the balance.

F2: On April 16, 2013, Jennifer Balliet was granted 7,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On March 5, 2014, Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F4: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F5: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.